# Erez Kaminski

> Erez Kaminski is the co-founder and CEO of Ketryx, a Cambridge-based software company that connects modern development tools with the evidence, traceability, risk controls, and approvals required for regulated products. A physics and mathematics graduate who worked at Wolfram Research and led AI and machine-learning work in Amgen's medical-device organization before earning an MBA and an MS in electrical engineering and computer science at MIT, he has built his career around translating complex systems into usable software. Ketryx, founded in 2021 with Jan Pöschko, raised a $39 million Series B in 2025 and says its platform supports products reaching more than 100 million patients worldwide.

- **Role:** Co-founder and CEO at Ketryx
- **Organizations:** Ketryx, Amgen, Wolfram Research, Massachusetts Institute of Technology, Association for the Advancement of Medical Instrumentation, Princeton Plasma Physics Laboratory, Birmingham-Southern College
- **Nationality:** Israeli
- **Education:** BS in Physics and Mathematics, Birmingham-Southern College, MBA and MS in Electrical Engineering and Computer Science, Leaders for Global Operations, Massachusetts Institute of Technology
- **Known for:** Co-founded Ketryx in 2021 and developed it into a connected lifecycle-management platform used by major regulated-product organizations., Raised a $39 million Series B for Ketryx in 2025, bringing publicly announced total funding above $55 million., Earned an MBA and an MS in electrical engineering and computer science from MIT in 2021.

## Career timeline

- **2009-2012** — Served in an Israel Defense Forces infantry unit and became a staff sergeant.
- **2014** — Worked as a research assistant at the Technion - Israel Institute of Technology on electric space propulsion.
- **2015-2016** — Conducted plasma-physics research at Princeton Plasma Physics Laboratory.
- **2016** — Graduated magna cum laude from Birmingham-Southern College with a degree in physics and mathematics and was elected to Phi Beta Kappa.
- **2016-2018** — Worked at Wolfram Research in technical, startup-program, and special-assistant roles.
- **2017** — Co-authored peer-reviewed research on kinetic simulations of electron plasma waves in Physical Review E.
- **2018-2019** — Worked in strategic planning and operations at Amgen, later leading AI and machine-learning initiatives for its medical-device organization.
- **2019-2021** — Completed an MBA and an MS in electrical engineering and computer science through MIT Leaders for Global Operations.
- **2021** — Co-founded Ketryx with Jan Pöschko and became CEO.
- **2022-present** — Serves as an AAMI working-group member focused on AI/ML risk management and cloud-enabled medical devices.
- **2025** — Led Ketryx through a $39 million Series B financing round.
- **2026** — Ketryx reported that its platform supported products reaching more than 100 million patients worldwide.

## Achievements

- Co-founded Ketryx in 2021 and developed it into a connected lifecycle-management platform used by major regulated-product organizations.
- Raised a $39 million Series B for Ketryx in 2025, bringing publicly announced total funding above $55 million.
- Earned an MBA and an MS in electrical engineering and computer science from MIT in 2021.
- Co-authored peer-reviewed plasma-physics research published in Physical Review E in 2017.
- Graduated magna cum laude from Birmingham-Southern College and was elected to Phi Beta Kappa.
- Received a Mathematical Association of America Outstanding Presentation Award in 2016.
- Contributes to AAMI working groups on AI/ML risk management and cloud-enabled medical devices.

## Latest updates

- **2026-04** — Appeared on The Lantern to discuss scaling regulated AI and Ketryx's growth following its Series B.
- **2026-03** — Ketryx announced a beta Model Context Protocol integration intended to bring compliance context into AI-assisted development workflows.
- **2026-02** — Ketryx reported that four of the five largest Fortune 500 medical-technology companies used its platform and that supported products reached more than 100 million patients.
- **2025-09** — Ketryx raised a $39 million Series B led by Transformation Capital, with participation from existing investors.
- **2025-07** — Ketryx announced an expansion into a 12,000-square-foot office at One Main Street in Cambridge.

## Links

- Website: https://www.ketryx.com
- LinkedIn: https://www.linkedin.com/in/erezkaminski
- Twitter/X: https://x.com/erez_kaminski
- YouTube: https://www.youtube.com/@Ketryx

---

Profile page: https://yespress.io/erez-kaminski
Published by YesPress — https://yespress.io
Last updated: 2026-08-26